Monday, 23 May 2016

Novartis executive exodus complicates drugmaker's rebuilding job

ZURICH (Reuters) - With seven departures in the space of five months, Novartis's top management is in upheaval just as CEO Joe Jimenez tries to tackle a list of challenges that have seen the drug firm's share price fall 25 percent since July.


No comments:

Post a Comment